{"AllianceGenome": "16510", "HGNC": "16510", "MIM": "609102", "_id": "79791", "_version": 1, "accession": {"genomic": ["AC010531.8", "CH471114.2", "CP068262.2", "NC_000016.10", "NC_060940.1", "NG_047196.1"], "protein": ["AAH12748.1", "AAL55855.1", "AAQ04213.1", "AAU50679.1", "CAB55929.2", "EAW95400.1", "EAW95401.1", "EAW95402.1", "EAW95403.1", "EAW95404.1", "NP_001269612.1", "NP_079011.3", "Q5XUX0.2"], "rna": ["AF318348.1", "AF428140.1", "AK311122.1", "AL117444.1", "AL576585.3", "AY736035.1", "BC002985.1", "BC012748.1", "BE465371.1", "BG718342.1", "BI596608.1", "BI914636.1", "BM151642.1", "BX106211.1", "BX329100.2", "DA493744.1", "DB444853.1", "NM_001282683.2", "NM_024735.5"], "translation": [{"protein": "AAL55855.1", "rna": "AF318348.1"}, {"protein": "AAU50679.1", "rna": "AY736035.1"}, {"protein": "NP_001269612.1", "rna": "NM_001282683.2"}, {"protein": "NP_079011.3", "rna": "NM_024735.5"}, {"protein": "CAB55929.2", "rna": "AL117444.1"}, {"protein": "AAH12748.1", "rna": "BC012748.1"}, {"protein": "AAQ04213.1", "rna": "AF428140.1"}]}, "alias": ["FBX14", "FBXO14", "Fbx31", "MRT45", "pp2386"], "ensembl": {"gene": "ENSG00000103264", "protein": ["ENSP00000310841", "ENSP00000455772", "ENSP00000479703", "ENSP00000490402"], "transcript": ["ENST00000311635", "ENST00000561664", "ENST00000563956", "ENST00000565593", "ENST00000567622", "ENST00000569412", "ENST00000618298", "ENST00000636077"], "translation": [{"protein": "ENSP00000490402", "rna": "ENST00000636077"}, {"protein": "ENSP00000310841", "rna": "ENST00000311635"}, {"protein": "ENSP00000455772", "rna": "ENST00000565593"}, {"protein": "ENSP00000479703", "rna": "ENST00000618298"}], "type_of_gene": "protein_coding"}, "entrezgene": "79791", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 16.3162478498, "exp_mis": 256.498916052, "exp_syn": 132.725058348, "lof_z": 3.51082122726572, "mis_z": 3.80223744149367, "mu_lof": 1.25397878621e-06, "mu_mis": 2.71588351752e-05, "mu_syn": 1.40184888556e-05, "n_lof": 2.0, "n_mis": 132.0, "n_syn": 121.0, "p_li": 0.911167117005807, "p_null": 2.75535962713794e-05, "p_rec": 0.0888053293979215, "syn_z": 0.630942106082327}, "bp": 1620, "cds_end": 87417350, "cds_start": 87364893, "n_exons": 9, "nonpsych": {"exp_lof": 14.6022647409, "exp_mis": 231.990763613, "exp_syn": 119.963470523, "lof_z": 3.23884649031935, "mis_z": 3.8741639856314, "mu_lof": 1.25397878621e-06, "mu_mis": 2.71588351752e-05, "mu_syn": 1.40184888556e-05, "n_lof": 2.0, "n_mis": 115.0, "n_syn": 112.0, "p_li": 0.860824967225516, "p_null": 0.000108705582149989, "p_rec": 0.139066327192334, "syn_z": 0.45776536727824}, "nontcga": {"exp_lof": 14.9948153511, "exp_mis": 235.962887073, "exp_syn": 122.090924767, "lof_z": 3.31040187832862, "mis_z": 3.79346463707653, "mu_lof": 1.25397878621e-06, "mu_mis": 2.71588351752e-05, "mu_syn": 1.40184888556e-05, "n_lof": 2.0, "n_mis": 119.0, "n_syn": 112.0, "p_li": 0.866946632667136, "p_null": 7.89586973786157e-05, "p_rec": 0.132974408635485, "syn_z": 0.578243230484905}, "transcript": "ENST00000311635.7"}, "exons": [{"cdsend": 87343738, "cdsstart": 87331287, "chr": "16", "position": [[87326986, 87331510], [87333885, 87334286], [87335303, 87335457], [87336154, 87336264], [87342876, 87342951], [87343597, 87343765], [87347173, 87347250], [87360294, 87360366], [87389736, 87389848], [87392082, 87392121]], "strand": -1, "transcript": "NM_001282683", "txend": 87392121, "txstart": 87326986}, {"cdsend": 87383744, "cdsstart": 87331287, "chr": "16", "position": [[87326986, 87331510], [87333885, 87334286], [87335303, 87335457], [87336154, 87336264], [87342876, 87342951], [87343597, 87343765], [87347173, 87347250], [87360294, 87360366], [87383404, 87383776]], "strand": -1, "transcript": "NM_024735", "txend": 87383776, "txstart": 87326986}], "exons_hg19": [{"cdsend": 87377344, "cdsstart": 87364893, "chr": "16", "position": [[87360592, 87365116], [87367491, 87367892], [87368909, 87369063], [87369760, 87369870], [87376482, 87376557], [87377203, 87377371], [87380779, 87380856], [87393900, 87393972], [87423342, 87423454], [87425688, 87425727]], "strand": -1, "transcript": "NM_001282683", "txend": 87425727, "txstart": 87360592}, {"cdsend": 87417350, "cdsstart": 87364893, "chr": "16", "position": [[87360592, 87365116], [87367491, 87367892], [87368909, 87369063], [87369760, 87369870], [87376482, 87376557], [87377203, 87377371], [87380779, 87380856], [87393900, 87393972], [87417010, 87417382]], "strand": -1, "transcript": "NM_024735", "txend": 87417382, "txstart": 87360592}], "generif": [{"pubmed": 16357137, "text": "Loss of FBXO31 is associated with breast cancer"}, {"pubmed": 19412162, "text": "ectopic expression of FBXO31 acts through a proteasome-directed pathway to mediate the degradation of cyclin D1, an important regulator of progression from G1 to S phase, resulting in arrest in G1"}, {"pubmed": 21537837, "text": "CGH array indicated that cases having cyclin D1 with increased copy number were significantly associated with elevated FBXO31 expression levels (P<0.05). FBXO31 could be a novel and robust prognostic marker for ESCC."}, {"pubmed": 22632973, "text": "The Skp2 SCF complex, not TRAF6, is a critical E3 ligase for ErbB-receptor-mediated Akt ubiquitination and membrane recruitment in response to EGF."}, {"pubmed": 23469015, "text": "ascribe a role for FBXO31 in dendrite growth and neuronal migration in the developing cerebellar cortex. Taken together, we uncovered the centrosomal E3 ligase FBXO31-SCF as a novel regulator of neuronal development"}, {"pubmed": 24623383, "text": "Truncation of the E3 ubiquitin ligase component FBXO31 causes non-syndromic autosomal recessive intellectual disability."}, {"pubmed": 24828503, "text": "FBXO31 interacts with Cdt1 and regulates the degradation of Cdt1 in G2 phase."}, {"pubmed": 24936062, "text": "uncover a new mechanism of deactivation of MKK6-p38 and substantiate a novel regulatory role of FBXO31 in stress response"}, {"pubmed": 25115392, "text": "Expression of FBXO31 inhibited xenograft tumor growth in mice. miR-20a and miR-17 mimics inhibited, whereas the inhibitor of miR-20a and miR-17 increased, the expression of FBXO31, respectively. miR-20a and miR-17 directly bind to the 3'-UTR of FBXO31."}, {"pubmed": 26124108, "text": "FBXO31-mediated loss of MDM2 leads to elevated levels of p53, resulting in growth arrest. In cells depleted of FBXO31, MDM2 is not degraded and p53 levels do not increase following genotoxic stress"}, {"pubmed": 28500896, "text": "FBXO31 targets and ubiquitylates Slug for proteasomal degradation. However, this mechanism is repressed in breast tumors where miR-93 and miR-106a are overexpressed. Our study further unravels an interesting mechanism whereby Slug drives the expression of miR-93 and miR-106a, thus establishing a positive feedback loop to maintain an invasive phenotype"}, {"pubmed": 28905993, "text": "in addition to revealing that FBXO31 is an independent prognostic marker for esophageal squamous cell carcinoma , our findings substantiate a novel regulatory role of FBXO31 in tumorigenesis and drug resistance of esophageal squamous cell carcinoma"}, {"pubmed": 29117943, "text": "Results identified FBXO31 as a novel E3 ubiquitin ligase of Snail1, and its low expression contributes to an aberrant accumulation of Snail1 in gastric cancer. Furthermore, F-box domain of FBXO31 and the phosphorylation of Snail1 are essential for the interaction and degradation. These findings reveal the important function of FBXO31 on the regulation of Snail1 protein level in gastric cancer."}, {"pubmed": 29279382, "text": "Findings indicate the substrate specificity of the F-box protein FBXO31 and the mechanism of FBXO31-regulated cyclin D1 protein turnover."}, {"pubmed": 29343641, "text": "results reveal how alterations in FBXO31 phosphorylation, mediated by AKT and ATM, underlie physiological regulation of FBXO31 levels in unstressed and genotoxically stressed cells"}, {"pubmed": 30341246, "text": "Higher mRNA expression levels of FBXO1, FBXO31, SKP2, and FBXO5 were significantly associated with worse prognosis for breast cancer patients. (Review)"}, {"pubmed": 31413110, "text": "FBXO31 plays a pivotal role in preserving genomic integrity by maintaining low cyclin A levels during the G1 phase for faithful genome duplication and segregation"}, {"pubmed": 32800832, "text": "F-box protein FBXO31 modulates apoptosis and epithelial-mesenchymal transition of cervical cancer via inactivation of the PI3K/AKT-mediated MDM2/p53 axis."}, {"pubmed": 32989326, "text": "Mutations disrupting neuritogenesis genes confer risk for cerebral palsy."}, {"pubmed": 33538099, "text": "MicroRNA-210 targets FBXO31 to inhibit tumor progression and regulates the Wnt/beta-catenin signaling pathway and EMT in esophageal squamous cell carcinoma."}, {"pubmed": 33675180, "text": "Variant recurrence confirms the existence of a FBXO31-related spastic-dystonic cerebral palsy syndrome."}, {"pubmed": 34686346, "text": "Loss of FBXO31-mediated degradation of DUSP6 dysregulates ERK and PI3K-AKT signaling and promotes prostate tumorigenesis."}, {"pubmed": 34706096, "text": "Feedback-regulated transcriptional repression of FBXO31 by c-Myc triggers ovarian cancer tumorigenesis."}, {"pubmed": 34839191, "text": "Effects and mechanisms of FBXO31 on Taxol chemoresistance in esophageal squamous cell carcinoma."}, {"pubmed": 35019165, "text": "Novel variants underlying autosomal recessive neurodevelopmental disorders with intellectual disability in Iranian consanguineous families."}, {"pubmed": 35940557, "text": "FBXO31 suppresses lipogenesis and tumor progression in glioma by promoting ubiquitination and degradation of CD147."}, {"pubmed": 36269678, "text": "FBXO31 sensitizes cancer stem cells-like cells to cisplatin by promoting ferroptosis and facilitating proteasomal degradation of GPX4 in cholangiocarcinoma."}, {"pubmed": 36803542, "text": "LincRNA ZNF529-AS1 inhibits hepatocellular carcinoma via FBXO31 and predicts the prognosis of hepatocellular carcinoma patients."}, {"pubmed": 37611899, "text": "Aberrantly High FBXO31 Impairs Oocyte Quality in Premature Ovarian Insufficiency."}, {"pubmed": 38216561, "text": "FBXO31 is upregulated by METTL3 to promote pancreatic cancer progression via regulating SIRT2 ubiquitination and degradation."}], "genomic_pos": {"chr": "16", "end": 87392142, "ensemblgene": "ENSG00000103264", "start": 87326987, "strand": -1}, "genomic_pos_hg19": {"chr": "16", "end": 87425748, "start": 87360593, "strand": -1}, "go": {"BP": [{"evidence": "IDA", "gocategory": "BP", "id": "GO:0006974", "pubmed": 19412162, "qualifier": "involved_in", "term": "DNA damage response"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0016567", "qualifier": "involved_in", "term": "protein ubiquitination"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0031145", "pubmed": 19412162, "qualifier": "involved_in", "term": "anaphase-promoting complex-dependent catabolic process"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0031146", "qualifier": "involved_in", "term": "SCF-dependent proteasomal ubiquitin-dependent protein catabolic process"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0031146", "pubmed": 19412162, "qualifier": "involved_in", "term": "SCF-dependent proteasomal ubiquitin-dependent protein catabolic process"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0031571", "pubmed": 19412162, "qualifier": "involved_in", "term": "mitotic G1 DNA damage checkpoint signaling"}], "CC": [{"evidence": "TAS", "gocategory": "CC", "id": "GO:0005829", "qualifier": "located_in", "term": "cytosol"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0019005", "qualifier": "part_of", "term": "SCF ubiquitin ligase complex"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0019005", "pubmed": 19412162, "qualifier": "part_of", "term": "SCF ubiquitin ligase complex"}, {"evidence": "ISS", "gocategory": "CC", "id": "GO:0043025", "qualifier": "located_in", "term": "neuronal cell body"}], "MF": [{"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": 19412162, "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0030332", "pubmed": 19412162, "qualifier": "enables", "term": "cyclin binding"}]}, "homologene": {"genes": [[7955, 555190], [8364, 779980], [9031, 100857445], [9544, 695313], [9598, 454297], [9606, 79791], [9615, 479620], [9913, 513951], [10090, 76454], [10116, 498959]], "id": 11684}, "interpro": [{"desc": "F-box only protein 31/39", "id": "IPR045048", "short_desc": "FBXO31/39"}, {"desc": "F-box domain", "id": "IPR001810", "short_desc": "F-box_dom"}, {"desc": "F-box-like domain superfamily", "id": "IPR036047", "short_desc": "F-box-like_dom_sf"}], "ipi": ["IPI00028347", "IPI00930569"], "map_location": "16q24.2", "name": "F-box protein 31", "other_names": ["F-box only protein 31", "SCF ubiquitin ligase specificity factor", "putative breast cancer tumor-suppressor"], "pantherdb": {"HGNC": "16510", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "1354708", "ortholog_type": "LDO", "panther_family": "PTHR10706", "taxid": 10090, "uniprot_kb": "Q3TQF0"}, {"RGD": "1561069", "ortholog_type": "LDO", "panther_family": "PTHR10706", "taxid": 10116, "uniprot_kb": "B2RYN2"}, {"Ensembl": "ENSGALG00000005779", "ortholog_type": "LDO", "panther_family": "PTHR10706", "taxid": 9031, "uniprot_kb": "A0A3Q2UD36"}, {"ZFIN": "ZDB-GENE-070628-4", "ortholog_type": "LDO", "panther_family": "PTHR10706", "taxid": 7955, "uniprot_kb": "E7F5P0"}, {"Ensembl": "ENSDARG00000110815", "ortholog_type": "O", "panther_family": "PTHR10706", "taxid": 7955, "uniprot_kb": "A0A2R8RR75"}, {"TAIR": "2082797", "ortholog_type": "LDO", "panther_family": "PTHR10706", "taxid": 3702, "uniprot_kb": "Q9M310"}], "uniprot_kb": "Q5XUX0"}, "pathway": {"reactome": [{"id": "R-HSA-1280218", "name": "Adaptive Immune System"}, {"id": "R-HSA-168256", "name": "Immune System"}, {"id": "R-HSA-392499", "name": "Metabolism of proteins"}, {"id": "R-HSA-597592", "name": "Post-translational protein modification"}, {"id": "R-HSA-8951664", "name": "Neddylation"}, {"id": "R-HSA-983168", "name": "Antigen processing: Ubiquitination & Proteasome degradation"}, {"id": "R-HSA-983169", "name": "Class I MHC mediated antigen processing & presentation"}]}, "pdb": ["5VZT", "5VZU"], "pfam": ["PF12014", "PF12937"], "pharmgkb": "PA28042", "pharos": {"target_id": 10154, "tdl": "Tbio"}, "pir": "T17239", "prosite": "PS50181", "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF268235", "relationship": "is"}, {"id": "GNF268236", "relationship": "is"}, {"id": "GNF268237", "relationship": "is"}, {"id": "GNF268238", "relationship": "is"}], "GNF_hs-Origene": {"id": "GNF046527", "relationship": "is"}, "GNF_hs-druggable_lenti-shRNA": [{"id": "GNF085992", "relationship": "is"}, {"id": "GNF085993", "relationship": "is"}, {"id": "GNF085994", "relationship": "is"}], "GNF_hs-druggable_plasmid-shRNA": [{"id": "GNF054300", "relationship": "is"}, {"id": "GNF059080", "relationship": "is"}, {"id": "GNF074408", "relationship": "is"}], "GNF_hs-druggable_siRNA": [{"id": "GNF067407", "relationship": "is"}, {"id": "GNF067408", "relationship": "is"}], "GNF_mm+hs-MGC": [{"id": "GNF004449", "relationship": "is"}, {"id": "GNF016635", "relationship": "is"}, {"id": "GNF017585", "relationship": "is"}], "GNF_mm+hs_RetroCDNA": {"id": "GNF235111", "relationship": "is"}, "NIBRI_hs-Secretome_pDEST": {"id": "GNF338672", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF104003", "relationship": "is"}, {"id": "GNF143652", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000016.10", "NC_060940.1", "NG_047196.1"], "protein": ["NP_001269612.1", "NP_079011.3"], "rna": ["NM_001282683.2", "NM_024735.5"], "translation": [{"protein": "NP_079011.3", "rna": "NM_024735.5"}, {"protein": "NP_001269612.1", "rna": "NM_001282683.2"}]}, "reporter": {"HG-U133_Plus_2": ["222352_at", "224162_s_at"], "HG-U95B": "55008_at", "HTA-2_0": ["TC16001330.hg.1", "TC16002016.hg.1"], "HuEx-1_0": "3703598", "HuGene-1_1": "8003249", "HuGene-2_1": "16829024"}, "retired": [25990, 84204, 114583], "summary": "This gene is a member of the F-box family. Members are classified into three classes according to the substrate interaction domain, FBW for WD40 repeats, FBL for leucing-rich repeats, and FBXO for other domains. This protein, classified into the last category because of the lack of a recognizable substrate binding domain, has been proposed to be a component of the SCF ubiquitination complex. It is thought to bind and recruit substrate for ubiquitination and degradation. This protein may have a role in regulating the cell cycle as well as dendrite growth and neuronal migration. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2013].", "symbol": "FBXO31", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1424342"}, "unigene": ["Hs.658034", "Hs.567582", "Hs.733212"], "uniprot": {"Swiss-Prot": "Q5XUX0", "TrEMBL": ["H3BQG7", "A0A0C4DGU8", "A0A1B0GV77"]}, "wikipedia": {"url_stub": "FBXO31"}}